4.3 Article

Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Targeted treatments of AL and ATTR amyloidosis

Pranav Chandrashekar et al.

Summary: The therapeutic landscape for cardiac amyloidosis is evolving rapidly, focusing on early identification and targeted therapy to prevent further deposition. Targeted therapeutics for transthyretin and light chain amyloidosis are being reviewed, with an emphasis on understanding the underlying mechanistic pathways of the diseases. Early recognition of cardiac adverse effects of therapies in patients with advanced amyloidosis can help prevent decompensation and guide therapy changes when necessary.

HEART FAILURE REVIEWS (2022)

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious and progressive infiltrative disease caused by the deposition of amyloid fibrils in the heart. With advances in imaging techniques and non-invasive diagnosis, it is now recognized as more common than traditionally believed. The Working Group on Myocardial and Pericardial Disease has proposed definitions, diagnostic algorithms, and treatment strategies to help bridge the gap between the latest research and clinical practice in managing cardiac amyloidosis.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy

Petar M. Seferovic et al.

Summary: Endomyocardial biopsy (EMB) is an invasive procedure commonly used for monitoring heart transplant rejection and diagnosing various cardiac disorders. Advances in EMB equipment and techniques have improved diagnostic precision. An expert consensus document provides a comprehensive overview on EMB, covering practical approaches, updated indications, revised surveillance plans, the impact of multimodality imaging, and current global clinical practices.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Medical Laboratory Technology

Diagnostic amyloid proteomics: experience of the UK National Amyloidosis Centre

Diana Canetti et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Review Oncology

Advances in the Treatment of Cardiac Amyloidosis

Ariane Vieira Scarlatelli Macedo et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)

Review Medicine, General & Internal

Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16, 175 Samples

Surendra Dasari et al.

MAYO CLINIC PROCEEDINGS (2020)

Review Neurosciences

Modulation of the Mechanisms Driving Transthyretin Amyloidosis

Filipa Bezerra et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Merrill D. Benson et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2020)

Article Cardiac & Cardiovascular Systems

Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis

Francesco Cappelli et al.

JOURNAL OF NUCLEAR CARDIOLOGY (2019)

Article Medicine, General & Internal

Cardiac amyloidosis : An update on diagnosis and treatment

Joseph P. Donnelly et al.

CLEVELAND CLINIC JOURNAL OF MEDICINE (2017)

Review Cardiac & Cardiovascular Systems

Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options

Hassan Alkhawam et al.

ACTA CARDIOLOGICA (2017)

Review Biochemical Research Methods

Advances in proteomic study of cardiac amyloidosis: progress and potential

Francesca Lavatelli et al.

EXPERT REVIEW OF PROTEOMICS (2016)

Article Cardiac & Cardiovascular Systems

AL (Light-Chain) Cardiac Amyloidosis A Review of Diagnosis and Therapy

Rodney H. Falk et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Review Cardiac & Cardiovascular Systems

Cardiac amyloidosis: pathology, nomenclature, and typing

Joseph J. Maleszewski

CARDIOVASCULAR PATHOLOGY (2015)

Article Biochemistry & Molecular Biology

Age-Related Oxidative Modifications of Transthyretin Modulate Its Amyloidogenicity

Lei Zhao et al.

BIOCHEMISTRY (2013)

Review Biochemistry & Molecular Biology

Islet Amyloid Polypeptide and Diabetes

Gunilla T. Westermark et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2013)

Article Biochemistry & Molecular Biology

Heparan Sulfate Dissociates Serum Amyloid A (SAA) from Acute-phase High-density Lipoprotein, Promoting SAA Aggregation

Fredrik Noborn et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein

Fredrik Noborn et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Oncology

Fibril protein fragmentation pattern in systemic AL-amyloidosis

Stina Enqvist et al.

JOURNAL OF PATHOLOGY (2009)

Article Biochemical Research Methods

Universal sample preparation method for proteome analysis

Jacek R. Wisniewski et al.

NATURE METHODS (2009)

Article Medicine, Research & Experimental

Two different types of amyloid deposits -: apolipoprotein A-IV and transthyretin -: in a patient with systemic amyloidosis

J Bergström et al.

LABORATORY INVESTIGATION (2004)